Should AKASA focus on enhancing its automated claim status checking feature or developing new machine learning models for denial management?

Introduction

The trade-off we're examining today is whether AKASA should focus on enhancing its automated claim status checking feature or developing new machine learning models for denial management. This decision is crucial for AKASA's product strategy and will significantly impact our resource allocation, user experience, and market positioning. I'll analyze this trade-off by considering various factors including business context, user impact, technical feasibility, and strategic alignment.

Step 1

Clarifying Questions (3 minutes)

• Based on our current market position, I'm thinking this decision might be driven by competitive pressures. Could you share more about how our competitors are performing in these two areas?

Why it matters: Helps prioritize which feature could give us a competitive edge Expected answer: Competitors are strong in claim status checking, but weak in denial management Impact on approach: Would lean towards developing denial management to differentiate

• Considering our user base, I'm assuming hospitals are our primary customers. Are there any specific segments within healthcare providers that are requesting either of these features more urgently?

Why it matters: Ensures we're addressing the most pressing needs of our key users Expected answer: Large hospital systems are pushing for improved denial management Impact on approach: Would prioritize denial management if it aligns with our highest-value customers

• From a technical standpoint, I'm curious about our current machine learning capabilities. Do we have the in-house expertise to develop new ML models for denial management, or would this require significant new hiring or outsourcing?

Why it matters: Assesses the feasibility and resource requirements for each option Expected answer: We have some ML expertise, but would need to expand the team Impact on approach: Might favor enhancing existing features if ML talent is scarce

• Regarding our product roadmap, I'm wondering how this decision aligns with our longer-term strategy. Are there any upcoming integrations or partnerships that would be impacted by focusing on one area over the other?

Why it matters: Ensures alignment with broader strategic initiatives Expected answer: Potential partnership with a major EHR system that could benefit from improved claim status checking Impact on approach: Might lean towards enhancing claim status checking to support strategic partnerships

• Considering our current financial situation, I'm curious about the potential revenue impact of each option. Do we have any projections on how each feature enhancement might affect our top line in the next 12-18 months?

Why it matters: Helps quantify the potential business impact of each option Expected answer: Denial management improvements could lead to higher revenue per customer Impact on approach: Would favor denial management if it shows significantly higher revenue potential